RxDoctor Payments Data
★ My doctorsLook up a doctor →

Elizabeth Diebel

Montgomery, ALNPI 1235281429

Payments from drug & device makers

$1,735in general payments, 2019–2025

Across 114 payments — averaging $15.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corium, LLC$446
  • GSK$250
  • Supernus Pharmaceuticals, Inc.$246
  • Ironshore Pharmaceuticals Inc.$145
  • Takeda Pharmaceuticals U.S.A., Inc.$116
  • Sanofi Pasteur Inc.$100
  • plus $431 from 10 others

What the payments were for

  • Food & beverage$1,735100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Corium, LLC30$446
GSK13$250
Supernus Pharmaceuticals, Inc.28$246
Ironshore Pharmaceuticals Inc.7$145
Takeda Pharmaceuticals U.S.A., Inc.6$116
Sanofi Pasteur Inc.6$100
Pfizer6$95
Seqirus USA Inc3$69
Merck3$52
Sanofi-aventis U.S. LLC2$46
Collegium Pharmaceutical, Inc.2$42
Sobi, Inc2$42
Neos Therapeutics, LP2$34
Shire North American Group Inc2$25
Genentech USA, Inc.1$16
Teva Pharmaceuticals USA, Inc.1$12

Where these figures come from

Is this you, or does something look wrong? →